Hong Kong
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 60.00 M
|
Dec. 31, 2023 | USD 17.19 | 2.12% |
|
Hong Kong |
|
2 |
USD 20.77 M
|
March 31, 2024 | USD 0.27 | 0.46% |
|
Hong Kong |
|
3 |
USD 15.36 M
|
Dec. 31, 2023 | USD 0.19 | -0.02% |
|
Hong Kong |
|
4 |
USD 5.85 M
|
Dec. 31, 2023 | USD 0.43 | -0.61% |
|
Hong Kong |
|
5 |
USD 5.24 M
|
June 30, 2024 | USD 3.80 | 0.53% |
|
Hong Kong |
|
6 |
USD -5.35 M
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
|
7 |
USD -13.65 M
|
Dec. 31, 2023 | USD 0.13 | -0.02% |
|
Hong Kong |
|
8 |
USD -18.59 M
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
9 |
USD -19.84 M
|
Dec. 31, 2023 | USD 0.52 | 0.23% |
|
Hong Kong |
|
10 |
USD -41.25 M
|
Dec. 31, 2023 | USD 0.80 | 2.57% |
|
Hong Kong |
|
11 |
USD -52.31 M
|
Dec. 31, 2023 | USD 0.44 | 1.16% |
|
Hong Kong |
|
12 |
USD -54.59 M
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
13 |
USD -62.29 M
|
Dec. 31, 2023 | USD 0.93 | 2.39% |
|
Hong Kong |
|
14 |
USD -67.27 M
|
Dec. 31, 2023 | USD 0.25 | -2.07% |
|
Hong Kong |
|
15 |
USD -81.96 M
|
Dec. 31, 2023 | USD 0.41 | 0.30% |
|
Hong Kong |
|
16 |
USD -82.95 M
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
17 |
USD -87.63 M
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
18 |
USD -106.62 M
|
Dec. 31, 2023 | USD 0.38 | 2.08% |
|
Hong Kong |
|
19 |
USD -138.08 M
|
Dec. 31, 2023 | USD 1.07 | 3.09% |
|
Hong Kong |
|
20 |
USD -219.30 M
|
Dec. 31, 2023 | USD 1.48 | 0.68% |
|
Hong Kong |
|
21 |
USD -264.67 M
|
Dec. 31, 2023 | USD 0.67 | 1.15% |
|
Hong Kong |
|
22 |
USD -291.14 M
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
23 |
USD -675.71 M
|
March 31, 2024 | USD 0.46 | 4.31% |
|
Hong Kong |
The Healthcare company in Hong Kong with the highest Net Cash Used For Investing Activities is BeiGene, Ltd. (HKSE: 6160.HK) at USD 60.00 M.
The Healthcare company in Hong Kong with the lowest Net Cash Used For Investing Activities is Alibaba Health Information Technology Limited (HKSE: 0241.HK) at USD -675.71 M.
The top 10 Healthcare companies in Hong Kong by Net Cash Used For Investing Activities are BeiGene, Ltd., Perfect Medical Health Management Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, Tycoon Group Holdings Limited, Regencell Bioscience Holdings Limited, Sirnaomics Ltd., SinoMab BioScience Limited, Lee's Pharmaceutical Holdings Limited, Modern Dental Group Limited and Guangdong Hybribio Biotech Co.,Ltd..
The bottom 10 Healthcare companies in Hong Kong by Net Cash Used For Investing Activities are Alibaba Health Information Technology Limited, HUTCHMED (China) Limited, China Resources Pharmaceutical Group Limited, The United Laboratories International Holdings Limited, Beijing Tong Ren Tang Chinese Medicine Company Limited, Sino Biopharmaceutical Limited, Frontage Holdings Corporation, Prenetics Global Limited, SSY Group Limited and China Traditional Chinese Medicine Holdings Co. Limited.